Current Search Criteria:
Intervention: Participants would receive 3 doses of Recombinant Hepatitis E Vaccine (Escherichia Coli) intramuscularly at 0, 1, 6 month.
Found 6 matching trials
Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine
PHASE2This phase ā
” clinical study was designed to evaluate the immunogenicity and...
Location
Multiple Locations
A Phase ā
£ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial)
PHASE4This study is to evaluate lot-lot consistency of Recombinant Hepatitis E Va...
Location
Dongtai City Center for Disease Control and Prevention
Safety and Immunogenicity Study of Thiomersal-free Hepatitis E Vaccine in People Ages 16 Years and Above
PHASE4The purpose of this study is to evaluate the safety and non-inferior immuno...
Location
Youxi County Center for Disease Control and Prevention
A Phase ā
£ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)
PHASE4This phase IV clinical study was designed to evaluate the safety and immuno...
Location
Kaihua Center for Disease Control and Prevention
A Phase ā
£ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )
PHASE4This phase IV clinical study was designed to evaluate the immunogenicity an...
Location
Rushan Center for Disease Control and Prevention
A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)
PHASE4This phase IV clinical study was designed to evaluate the immunogenicity an...
Location
Changshan Center for Disease Control and Prevention